collection
MENU ▼
Read by QxMD icon Read
search

Peyronies

shared collection
8 papers 0 to 25 followers
https://www.readbyqxmd.com/read/27746896/-recent-advances-in-managing-peyronie-s-disease
#1
Oliver Kayes, Rauf Khadr
Peyronie's disease remains an under-reported and debilitating problem which can result in significant physical and psychological symptoms for some men. The classic symptom complex includes penile curvature, penile plaque, and penile pain. Men can also present with erectile dysfunction, penile instability, and penile shortening, alongside feelings of low mood/libido, dysmorphobia, and low self-esteem. This review highlights the current key publications in the medical literature and provides updates on new clinical therapies whilst postulating about potential future treatments on the horizon...
2016: F1000Research
https://www.readbyqxmd.com/read/27785836/effect-of-rutin-on-diabetic-induced-erectile-dysfunction-possible-involvement-of-testicular-biomarkers-in-male-rats
#2
A S Al-Roujeaie, H M Abuohashish, M M Ahmed, O A Alkhamees
The present study aimed to investigate effects of rutin on diabetic-induced impairments of sexual behaviour, spermatogenesis and oxidative testicular damage. Diabetes was induced by a single injection of STZ (65 mg/kg) in male adult Wistar rats. Two weeks later, rutin (50 and 100 mg kg(-1)  day(-1) ) was treated to normal and diabetic rats for 5 weeks. Sexual behaviour of the animals was observed by taking stimulus females. At the end of the study, sperm count, motility and viability were recorded. Serum levels of glucose, inflammatory markers and testosterone were also estimated...
October 26, 2016: Andrologia
https://www.readbyqxmd.com/read/26770906/efficacy-and-safety-evaluation-of-pentoxifylline-associated-with-other-antioxidants-in-medical-treatment-of-peyronie-s-disease-a-case-control-study
#3
Gianni Paulis, Davide Barletta, Paolo Turchi, Antonio Vitarelli, Giuseppe Dachille, Andrea Fabiani, Romano Gennaro
Peyronie's disease (PD) is a chronic disorder involving the tunica albuginea surrounding the corpora cavernosa of the penis. A conservative treatment is indicated in the first stage of disease. The aim of this study was to assess the therapeutic impact and possible side effects of treatment with pentoxifylline (PTX) in combination with other antioxidants in 307 patients with early-stage PD. Patients were subdivided into three groups: A, B, and C. Both groups, A and B, comprising of 206 patients, underwent treatment, whereas Group C was the control group (n=101)...
2016: Research and Reports in Urology
https://www.readbyqxmd.com/read/26762220/surgical-treatment-of-peyronie-s-disease-with-autologous-tunica-vaginalis-of-testis
#4
Bianjiang Liu, Quan Li, Gong Cheng, Ninghong Song, Min Gu, Zengjun Wang
BACKGROUND: To investigate the feasibility and safety of surgical treatment for Peyronie's disease (PD) by excising and repairing plaque using autologous tunica vaginalis of testis. METHODS: From March 2007 to December 2012, total 19 patients with PD underwent surgical treatment at our center. All patients had significant phallocampsis during erection. All patients complained of decreased sexual function. During the operation, the fibrotic plaque was excised and neurovascular bundle (NVB) was spared...
January 13, 2016: BMC Urology
https://www.readbyqxmd.com/read/26491251/role-of-collagenase-clostridium-histolyticum-in-peyronie-s-disease
#5
REVIEW
Taylor C Peak, Gregory C Mitchell, Faysal A Yafi, Wayne J Hellstrom
Peyronie's disease is a localized connective tissue disease characterized by an active, inflammatory phase and a stable, quiescent phase, with the eventual development of collagenous plaques within the tunica albuginea of the penis. Risk factors primarily associated with Peyronie's disease include Dupuytren's contracture, penile trauma, and family history. A variety of treatment strategies have been utilized, including oral and topical agents, electromotive drug administration, intralesional injections, extracorporeal shockwave therapy, penile traction, and surgery...
2015: Biologics: Targets & Therapy
https://www.readbyqxmd.com/read/26257044/intralesional-hyaluronic-acid-an-innovative-treatment-for-peyronie-s-disease
#6
Romano Gennaro, Davide Barletta, Gianni Paulis
OBJECTIVE: The significantly different effects of several conservative treatments for Peyronie's disease (PD) led us to conduct this study to evaluate the effectiveness of local treatment with injectable hyaluronic acid (HA) for patients with this disease. MATERIALS AND METHODS: The study included 83 PD patients who underwent treatment and 81 PD patients who did not (control group). The inclusion criteria were: penile plaque volume <1 cm(3); clinical characteristics and ultrasonographic appearance compatible with active inflammation; and penile curvature <45°...
October 2015: International Urology and Nephrology
https://www.readbyqxmd.com/read/26229323/tadalafil-once-daily-and-intralesional-verapamil-injection-a-new-therapeutic-direction-in-peyronie-s-disease
#7
Lucio Dell'Atti
INTRODUCTION: The aim of this study was to evaluate the combination of intralesional verapamil injection (IVI) therapy with and tadalafil in men affected by Peyronie's disease (PD). MATERIALS AND METHODS: In this study, 59 patients diagnosed with PD, were divided into three groups. Group A (GA) counted 23 patients treated with IVI; Group B (GB) treated 19 patients with tadalafil 5 mg once a day, and Group C (GC) treated 17 patients with IVI and tadalafil for 3 months...
July 2015: Urology Annals
https://www.readbyqxmd.com/read/26144333/intralesional-injection-of-interferon-%C3%AE-2b-improves-penile-curvature-in-men-with-peyronie-s-disease-independent-of-plaque-location
#8
Carrie A Stewart, Faysal A Yafi, Margaret Knoedler, Sree H Mandava, Ian R McCaslin, Premsant Sangkum, Suresh Sikka, Landon Trost, Wayne J G Hellstrom
PURPOSE: Collagenase clostridium histolyticum is the only FDA (Food and Drug Administration) approved treatment for Peyronie's disease. However, to our knowledge collagenase clostridium histolyticum has not been studied in men with ventral plaques. Given this limitation and the paucity of literature on ventral plaque outcomes, we compared the results of Peyronie's disease treatment in men with different plaque locations treated with intralesional interferon-α2b. MATERIALS AND METHODS: We retrospectively analyzed the records of men treated with intralesional interferon-α2b for Peyronie's disease at 1 institution from 2001 to 2014...
December 2015: Journal of Urology
1
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"